
EUCOPE's Sounds of Science - Episode 18
On this episode, we talk about the revision of the General Pharmaceutical Legislation (GPL). We discuss the reports adopted on 10 April by the European Parliament, less than a year after the Commission’s proposal was released, focusing on the incentives framework and the regulatory provisions. Not only we will discuss the proposals adopted by the Parliament, but we’ll compare them with the Commission’s approach. We will also share our thoughts on how the revised framework might impact small and mid-sized companies and their investments in innovative treatments in Europe.
The guests of this episode are: